ATLANTA, GA – – (Newsfile Corp. – August 13, 2021) – – Holzer & Holzer, LLC is investigating whether LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) complied with federal securities laws. On August 11, 2021, LifeStance, one of the largest providers of mental healthcare in the United States, announced financial results for the second quarter, reporting a $70 million net loss. LifeStance also provided disappointing estimates for third quarter, which was below analysts’ consensus. During the earnings call, senior management reported that the Company saw increased clinician turnover, indicating that “new clinicians additions have lower productivity for the first four to six months and therefore, will not immediately offset the impact from higher turnover, a dynamic we expect to negatively impact center margin and adjusted EBITDA by approximately 7 to 9 million.” On this news, the price of the Company’s stock plummeted. If you purchased LifeStance stock and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at email@example.com or Joshua Karr, Esq. at firstname.lastname@example.org, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com to discuss your legal rights.